These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Construction and testing of a novel host-range defective myxoma virus vaccine with the M063 gene inactivated that is non-permissive for replication in rabbit cells. Adams MM, van Leeuwen BH, McFadden G, Kerr PJ. Vet Res; 2008; 39(6):60. PubMed ID: 18778680 [Abstract] [Full Text] [Related]
5. Genetic Variability of Myxoma Virus Genomes. Braun C, Thürmer A, Daniel R, Schultz AK, Bulla I, Schirrmeier H, Mayer D, Neubert A, Czerny CP. J Virol; 2017 Feb 15; 91(4):. PubMed ID: 27903800 [Abstract] [Full Text] [Related]
6. Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions. Adams MM, van Leeuwen BH, Kerr PJ. Vaccine; 2008 Oct 29; 26(46):5843-54. PubMed ID: 18789367 [Abstract] [Full Text] [Related]
8. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain. Marlier D, Mainil J, Boucraut-Baralon C, Linden A, Vindevogel H. J Comp Pathol; 2000 Oct 29; 122(2-3):115-22. PubMed ID: 10684680 [Abstract] [Full Text] [Related]
10. Vaccine breaks: Outbreaks of myxomatosis on Spanish commercial rabbit farms. Dalton KP, Nicieza I, de Llano D, Gullón J, Inza M, Petralanda M, Arroita Z, Parra F. Vet Microbiol; 2015 Aug 05; 178(3-4):208-16. PubMed ID: 26009303 [Abstract] [Full Text] [Related]
17. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Best SM, Kerr PJ. Virology; 2000 Feb 01; 267(1):36-48. PubMed ID: 10648181 [Abstract] [Full Text] [Related]